Category: News
-
Common Food Preservatives Linked to Diabetes and Cancer
Food preservatives are everywhere. They help keep packaged foods fresh, prevent mold and bacteria, and extend shelf life. Without them, many grocery store staples wouldn’t last long enough to make it from factory to kitchen. But growing research suggests that some commonly used food preservatives may be linked to higher risks of serious health conditions,
-
FDA Expands Addyi Approval to Treat Postmenopausal Libido – What It Means and What to Know
Low sexual desire after menopause is common, and on December 15, 2025 the FDA expanded the label for Addyi (flibanserin) to include some postmenopausal women. This is a notable change: Addyi was first approved in 2015 for certain premenopausal women, and the new decision gives doctors another FDA‑cleared option for women under 65 who meet
-
Second Measles Surge of 2025: Why South Carolina’s Outbreak Is Accelerating and What You Need to Know
Measles is back in the headlines. After a major outbreak earlier this year, the United States is now seeing a second surge of measles cases, and one of the fastest-growing clusters is in South Carolina’s Upstate region. This post explains, in plain language, what’s happening, why it matters, and what you can do to protect
-
FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy — Itvisma (onasemnogene abeparvovec‑brve)
Background and mechanism Spinal muscular atrophy (SMA) is an autosomal‑recessive neurodegenerative disorder caused by loss‑of‑function mutations in the SMN1 gene, resulting in reduced survival motor neuron (SMN) protein, progressive motor neuron loss, and muscle atrophy. Gene‑replacement therapy using adeno‑associated virus (AAV) vectors delivers a functional copy of SMN1 to motor neurons, restoring SMN protein expression
-
CDC’s Shift on Vaccine and Autism Stance Nov 2025
Has the CDC Quietly Changed Its Stance on Vaccines and Autism? On November 19–20, 2025, the U.S. Centers for Disease Control and Prevention (CDC) made a significant and abrupt revision to its public-facing guidance on the relationship between vaccines and autism. This change, which replaced longstanding language unequivocally stating that vaccines do not cause autism
-
Can Viagra (Sildenafil) Reverse Damage in Genetic Deafness?
Hearing loss is a pervasive global health issue, affecting over 1.5 billion people worldwide, with sensorineural hearing loss (SNHL) accounting for the vast majority of cases. SNHL arises from damage to the delicate sensory hair cells or neurons within the cochlea, and until recently, such damage – especially when caused by genetic mutations – was
-
Marburg Virus in Ethiopia 2025: Outbreak Analysis, Challenges, and Global Preparedness
In November 2025, Ethiopia faced a historic and urgent public health challenge: its first confirmed outbreak of Marburg virus disease (MVD) in the southern Omo region, specifically in Jinka town. This event not only marked a significant milestone in the country’s epidemiological history but also raised pressing questions about regional preparedness, cross-border risks, and the
-
Rising Measles Cases in the United States
A Dangerous Resurgence Measles, once declared eliminated in the United States in 2000, has roared back in 2025 with a vengeance. The Centers for Disease Control and Prevention (CDC) reports 1,681 confirmed cases this year, a staggering increase from 285 in 2024. This marks the highest annual total since the early 1990s. The virus has
-
Why More Americans Are Ditching Traditional Health Care for New Models in 2026
A Healthcare Revolution in Motion Across the United States, the way people find and experience health care is changing dramatically. Long gone are the days when nearly everyone relied on the familiar duo of a family doctor’s office and hospital networks, with insurance cards always at the ready. In their place, innovative – and sometimes
-
FDA Recalls 141,984 Bottles of Atorvastatin Calcium After Failed Dissolution Testing
On 10 October 2025 the U.S. Food and Drug Administration (FDA) classified a nationwide recall of Atorvastatin Calcium tablets, initiated by Ascend Laboratories, LLC, as a Class II recall because multiple lots “failed dissolution specifications,” affecting 141,984 bottles distributed across the United States. The recalled product is a generic formulation of atorvastatin (a statin widely